Sommaire

Numéro précédent | Numéro suivant

• Podium Sessions

  • ·POD-1.01: The Effect of Nerve-Sparing Status in the Recovery of Continence after Radical Prostatectomy

    Page :S1

    Y. Choi, Y. Chae, S. Chung, K. Cho, W. Ham

    Plan Plan
  • ·POD-1.02: Treatment of refractory postoperative urinary stress incontinence by the use of autologous satellite cells (SLC)

    Page :S1

    R. Karig, B. Jens, H. Gerullis, E. Christoph, R. Albert, O. Thomas

    Plan Plan
  • ·POD-1.03: Mid-term results of the functional transobturator sling suspension for male post-prostatectomy stress urinary incontinence

    Page :S1

    R. Bauer, C. Füllhase, A. Becker, C. Stief, I. Soljanik

    Plan Plan
  • ·POD-1.04: The bone-anchored perineal male sling for post-prostatectomy incontinence: results up to 5 years of follow-up

    Page :S2

    M. Guimaraes, R. Oliveira, A. Resende, P. Dinis, F. Pina, F. Cruz

    Plan Plan
  • ·POD-1.05: Long term results after AdVance male sling procedure in male stress urinary incontinence (SUI)

    Page :S2

    A. Hegele, C. Frohme, P. Olbert, R. Hofmann

    Plan Plan
  • ·POD-1.06: Male slings: a comparative study of two techniques

    Page :S2

    M. Crites, G. Ghoniem

    Plan Plan
  • ·POD-1.07: Treatment of stress urinary incontinence due to neurogenic sphincter insufficiency using the AdVance male sling

    Page :S3

    R. Gómez, D. Staneck, A. Vidal, G. Catalan, O. Castillo, R. Campos, K. McCammon

    Plan Plan
  • ·POD-1.08: The artificial urinary sphincter: a contemporary series

    Page :S3

    P. Kumar, D. Summerton, T. Terry

    Plan Plan
  • ·POD-1.09: AdVance sling: the ‘repositioning test', the most important tool for preoperative evaluation

    Page :S4

    R. Bauer, C. Füllhase, C. Stief, I. Soljanik

    Plan Plan
  • ·POD-2.01: Retropubic bulbourethral sling in children with post-exstrophy incontinence: preliminary report

    Page :S4

    B. Wadie, T. Helmy, M. Dawaba

    Plan Plan
  • ·POD-2.02: Outcome of dual flange metallic sphincteric urethral stents in the treatment of neuropathic bladder dysfunction after spinal cord injury

    Page :S4

    A. Van Der Merwe, E. Baalbergen, R. Shrosbree, C. Heyns

    Plan Plan
  • ·POD-2.03: Can we predict complications from known classifications of neurogenic voiding dysfunction?

    Page :S4

    S. Kim, J. Song, K. Kim, H. Chung, J. Jung

    Plan Plan
  • ·POD-2.04: Neurogenic detrusor overactivity in adults: a review of the efficacy of oral antimuscarinics

    Page :S5

    H. Madersbacher, G. Mürtz, M. Stöhrer

    Plan Plan
  • ·POD-2.05: Reality of Urinary Incontinence in Patients with Parkinson's Disease

    Page :S5

    Y. Kim, J. Lee

    Plan Plan
  • ·POD-2.06: Effect of t-type calcium channel blocker mibefradil on cyclophosphamide-induced cystitis in mouse

    Page :S6

    H. You, D. Lee, S. Lee, J. Kim, S. Chang, J. Ahn

    Plan Plan
  • ·POD-2.07: Laparoscopic augmentation ileocystoplasty: urodynamic findings and long-term outcome

    Page :S6

    M. Abdel Hakim, A. El Feel, A. Abdel Hakim

    Plan Plan  
  • ·POD-2.08: Bladder augmentation for hyperactive spinal cord neurogenic bladder: comparison of open versus laparoscopic ileocystoplasty

    Page :S7

    R. Gómez, P. Marchetti, G. Catalan, A. Vidal, O. Castillo

    Plan Plan
  • ·POD-2.09: Real-time MRI for visualization of differences in continent and incontinent patients with neobladder

    Page :S7

    R. Bauer, A. Rooseb, C. Stief, Y. Hocaoglu

    Plan Plan
  • ·POD-2.10: Surgery of the spinal cord injury neurogenic bladder: a 23 year experience

    Page :S7

    R. Gómez, G. Catalan, A. Vidal, C. Parra

    Plan Plan

• Moderated Poster Sessions

  • ·MP-01.01: The effect of anticholinergics to benign prostatic hyperplasia patients with overactive bladder symptoms and the risk factors to affect patient's satisfaction

    Page :S9

    W. Cho, T. Kim, J. Yoon

    Plan Plan
  • ·MP-01.02: Diagnostic performance of simple tests used by general practitioners in identifying benign prostatic hyperplasia (BPH): results from the D-IMPACT (Diagnosis Improvement in Primary Care Trial) study

    Page :S9

    R. Fourcade, J. Carballido, A. Sessa, F. Brenes, C. Cricelli, M. Gilson, M. Roset, R. Castro

    Plan Plan
  • ·MP-01.03: Lower urinary tract symptoms, benign prostatic hyperplasia, and metabolic syndrome

    Page :S9

    F. Rusu, E. Rusu, G. Radulian, C. Pricop, V. Jinga, D. Cheta, D. Mischianu

    Plan Plan
  • ·MP-01.04: Prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms

    Page :S10

    C. Van Der Walt, A. Groeneveld, S. Van Vuuren, R. Edlin, C. Heyns

    Plan Plan  
  • ·MP-01.05: Sexual dysfunction in patients with LUTS due to benign prostatic enlargement

    Page :S10

    M. Ali, I. Ismail, M. Metawea, M. Bakr, H. Rashwan

    Plan Plan
  • ·MP-01.06: Impact of erectile function in men with lower urinary tract symptoms on ejaculatory function

    Page :S11

    S. Kam, J. Jung

    Plan Plan
  • ·MP-01.07: LUTS and semen quality of Korean men in their 4th decade

    Page :S11

    C. Bak, S. Song, D. Park, S. Shim, T. Yoon, J. Lim

    Plan Plan
  • ·MP-01.08: Does the effect of alpha-blockers in a patient with a small prostate differ urodynamically from one with a large prostate?

    Page :S11

    H. Iuchi, Y. Watabe, H. Hashimoto, N. Wada, H. Kakizaki, H. Tsurukawa

    Plan Plan
  • ·MP-01.09: Tailoring pharmacotherapy of male lower urinary tract symptoms with ⍺-blockers, ⍺-reductase inhibitors, and antimuscarinics

    Page :S12

    K.S. Lee, H.Y. Choi, K.S. Lee, H.N. Lee, Y.S. Lee, S.E. Lee, M.S. Choo, W.H. Park

    Plan Plan
  • ·MP-01.10: Efficacy of tamsulosin OCAS^™ plus solifenacin (TOCAS+Soli) in male LUTS: results from a randomized, dose-ranging, phase II trial (SATURN)

    Page :S12

    P. Van Kerrebroeck, M. Oelke, F. Katona, A. Garcia-Hernandez, M. Klaver

    Plan Plan
  • ·MP-01.11: Outpatient work-up for LUTS: an assignment for specially trained nurses (STNs)?

    Page :S13

    P. Ströberg, V. Elf, A. Eleholt

    Plan Plan
  • ·MP-01.12: Outcomes of patients treated medically for benign prostatic hyperplasia (BPH) in French general practice

    Page :S13

    R. Fourcade, F. Lacoin, A. Slama, A. Gaudin, C. Le Fur, E. Michel, A. Sitbon, F. Cotté

    Plan Plan
  • ·MP-01.13: Actual medical management of LUTS/BPH across Europe beyond official clinical guidelines: a wide population study

    Page :S14

    J. Cornu, J. Terrasa, M. Tligui, P. Sébe, C. Ciofu, L. Peyrat, O. Traxer, O. Cussenot, F. Haab, B. Lukacs

    Plan Plan
  • ·MP-01.14: Benign prostatic hyperplasia: where evidence-based medicine should face reality

    Page :S14

    J. Cornu, M. Aout, V. Moysan, C. Hodde, A. Fournier, E. Vicaut, B. Lukacs

    Plan Plan
  • ·MP-02.01: Management of adult anterior urethral stricture disease: nationwide survey among urologists in the Netherlands

    Page :S15

    M. Van Leeuwen, J. Brandenburg, E. Kok, P. Vijverberg, J. Bosch

    Plan Plan
  • ·MP-02.02: Predictors of recurrence in optical urethrotomy (OU) for male urethral strictures

    Page :S15

    A. Zehri, M. Ather, Q. Afshan

    Plan Plan
  • ·MP-02.03: Results of dorsal buccal graft augmented anastomosis for urethral strictures

    Page :S15

    B. Tisdale, E. Grossgold, C. Bayne, L. Parrillo, J. Tonkin, K. McCammon, G. Jordan

    Plan Plan
  • ·MP-02.04: Versatility of ventral onlaid buccal mucosal graft urethroplasty in treatment of penile and meatal strictures in conjunction with the dartos fascial flap

    Page :S16

    J. Wong

    Plan Plan
  • ·MP-02.05: Urinary function and QOL in men >60 undergoing perineal urethrostomy vs. urethral reconstruction

    Page :S16

    H. Wood, T. Gao, K. Angermeier

    Plan Plan
  • ·MP-02.06: Erectile function after end-to-end repair, buccal mucosa roof strip augmented anastomosis or dorsal-inlay buccal mucosa graft urethroplasty for single-stage bulbar urethroplasty

    Page :S17

    K. Vander Eeckt, S. Joniau

    Plan Plan  
  • ·MP-02.07: Wound complications after urethral reconstruction and the effect of a monocryl mattress closure on healing

    Page :S18

    K. Rourke, A. Kinnaird

    Plan Plan
  • ·MP-02.08: Long-term outcomes of urethral reconstruction: risk factors for stricture recurrence

    Page :S18

    K. Rourke, B. St. Martin

    Plan Plan
  • ·MP-02.09: Treatment of urethral stricture disease at the Department of Urology, University of the Free State, South Africa: patient profile, management and outcome

    Page :S18

    F. Claassen, S. Wentzel, G. Joubert

    Plan Plan
  • ·MP-02.10: Vesico-vaginal fistula repair: unique experience in young multigravida, multicaesarian patients from Jazan region, Saudi Arabia

    Page :S19

    A. Jha, Z. Roshdi, M. Tohari, H. Al Faifi

    Plan Plan
  • ·MP-02.11: Application of small intestinal submucosa graft in repair of complicated vesico-vaginal fistula: pilot study

    Page :S19

    M. Rasheed, Y. Farahat, A.E. Elbahnasy, M. Gaber, S. Mourad

    Plan Plan
  • ·MP-02.12: A versatile labia minora skin flap in severe vesicovaginal fistula repair

    Page :S19

    M. Bizic, V. Kojovic, M. Majstorovic, G. Korac, M. Djordjevic

    Plan Plan
  • ·MP-02.13: Laparoscopic vesicovaginal fistula repair: 9 cases

    Page :S20

    O. Castillo, A. Foneron, R. Gómez, I. Vidal-Mora, G. Rubio, R. Campos

    Plan Plan
  • ·MP-02.14: The Effect of intra-corpus spongiosum mitomycin-c injection therapy combined with optic internal urethrotomy in the treatment of anterior urethral strictures: does it improve the treatment outcome?

    Page :S20

    F. Claassen, S. Wentzel, G. Joubert

    Plan Plan
  • ·MP-02.15: Adult urethral strictures in previous hypospadias patients

    Page :S20

    V. Kojovic, M. Majstorovic, M. Bizic, G. Korac, M. Djordjevic

    Plan Plan
  • ·MP-02.16: Preliminary results of mitomycin on recurrent bladder neck contracture after radical prostatectomy

    Page :S21

    M. Bettez, L.M. Tu

    Plan Plan
  • ·MP-02.17: Bladder outlet obstruction (BOO) post BPH surgery: over 3 years' follow-up using holmium laser: our department experience

    Page :S21

    R. Giulianelli, F. Pisanti, B. Gentile, S. Brunori, L. Mavilla, L. Albanesi, F. Attisani, T. Shestani, G. Vincenti

    Plan Plan
  • ·MP-03.01: In vitro test system for the evaluation of the biocompability of alloplastic materials and its improvement by autologous coating

    Page :S21

    J. Bagner, H. Gerullis, R. Karig, A. Ramon, T. Otto

    Plan Plan
  • ·MP-03.02: The expression of transient receptor potential channels in the urothelium of rats with detrusor overactivity induced by bladder outlet obstruction

    Page :S22

    C.K. Sul, S. Lee

    Plan Plan
  • ·MP-03.03: Bladder outlet obstruction modulates Ca2+ sensitization in alpha-toxin permeabilized guinea-pig detrusor smooth muscle

    Page :S22

    N. Shahab, S. Kajioka, T. Yunoki, N. Seki, S. Naito

    Plan Plan
  • ·MP-03.04: The effect of continuous PDE-5 inhibitors in CPPS

    Page :S22

    D. Cho, J. Yeo, H. Park, J. Park

    Plan Plan
  • ·MP-03.05: The collagen composition of the bladder wall extracellular matrix is influenced by hypercholesterolemic diet in rats

    Page :S23

    R. Nunes, H. Bruschini, K. Utsunomia, M. Silveira, W. Teodoro, K. Leite, M. Srougi

    Plan Plan
  • ·MP-03.06: A fluid dynamic model matched for voiding dysfunction in bladder outlet obstruction

    Page :S23

    G. Sakuyama, T. Ishii, Y. Naya, T. Yamanishi, T. Igarashi

    Plan Plan  
  • ·MP-03.07: Does finasteride have a preventive effect on a chronic bacterial prostatitis? Pilot study using an animal model

    Page :S24

    Y. Cho

    Plan Plan
  • ·MP-03.08: Significance of histological evidence of prostatitis in men with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate

    Page :S24

    S. Van Vuuren, A. Zarrabi, C. Heyns

    Plan Plan
  • ·MP-03.09: The levels of serum C-reactive protein and urinary nerve growth factor in patients with OAB and IC/BPS

    Page :S25

    Y. Tseng, S. Chung, H. Liu, H. Kuo

    Plan Plan
  • ·MP-03.10: Urinary nerve growth factor in OAB and cystitis

    Page :S25

    H. Yoon, J. Seo, D. Lee

    Plan Plan
  • ·MP-03.11: Improvement of pain and sleep problems by urine alkalinization in patients with interstitial cystitis

    Page :S26

    K. Drasa

    Plan Plan
  • ·MP-03.12: The effect of tamsulosin 0.2mg in patients with chronic pelvic pain syndrome: multicenter, randomized, prospective study

    Page :S26

    T.H. Kim, W. Cho, J. Yoon, D. Kim

    Plan Plan
  • ·MP-03.13: Hyperbaric oxygen (HBO) therapy suppresses the symptoms in painful bladder syndrome/interstitial cystitis (PBS/IC) resistant to conventional treatments: long-term result of a pilot study in Japan

    Page :S27

    T. Tanaka, K. Kuratsukuri, R. Yoshimura, K. Morimoto, N. Nishikawa, T. Nakatani

    Plan Plan
  • ·MP-03.14: One-year follow-up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomized placebo-controlled double blind study

    Page :S27

    R. Zimmermann, A. Cumpanas, G. Janetschek

    Plan Plan
  • ·MP-03.15: Ketamine abuse: new causative factor of LUTS

    Page :S28

    S. Middela, I. Pearce

    Plan Plan
  • ·MP-03.16: The role of effect of Cav3.2/ alpha1h t-type calcium channel on voiding

    Page :S28

    D.K. Lee, J. Ahn, S. Lee, J. Kim, S. Chang

    Plan Plan
  • ·MP-04.01: A 5-year follow up of the transobturator tape as a means of surgical treatment of stress urinary incontinence in an Indian scenario

    Page :S28

    S. Bapat, A. Talaulikar, Y. Sovani, R. Sharma, Y. Kshirsagar, A. Mulay, H. Chaudhary, V. Paramne

    Plan Plan
  • ·MP-04.02: Urethral bulking agent trials: a review and comparison of analysis methodology utilized in trial outcomes

    Page :S29

    G. Ghoniem

    Plan Plan  
  • ·MP-04.03: Randomized control study of MONARC vs. tension free vaginal tape obturator (TVT-O) in the management of female incontinence in comparison of medium-term cure rate

    Page :S29

    D. Kim, C. Park

    Plan Plan
  • ·MP-04.04: Comparison of TVT-SECUR and transobturator tape for outcome and patient satisfaction in female stress urinary incontinence

    Page :S30

    J. Kim, J.H. Kim, D. Lee, W. Park, S. Kim, J. Choi, H. Kim

    Plan Plan
  • ·MP-04.05: Transobturator suburethral tape (TOT) vs single incision sling system (TVT-Secur System, TVT-S): comparison of efficacy for mixed urinary incontinence

    Page :S30

    G. Kim, J. Seo, D. Cho, J. Lee, H. Seo, J. Kim, W. Lee, Y. Seo, H. Kim, D. Kim

    Plan Plan
  • ·MP-04.06: Influences of preoperative physical examination and urodynamic study parameters on postoperative voiding dysfunctions in patients with urodynamic stress incontinence

    Page :S30

    S. Cho, Y. Lee, K. Kim

    Plan Plan
  • ·MP-04.07: TOT approach in stress urinary incontinence (SUI): outcome in obese female

    Page :S31

    A. Hegele, Z. Varga, C. Frohme, R. Hofmann, F. Ludt

    Plan Plan
  • ·MP-04.08: The effect of body mass index on the result of the SPARC in patients with stress urinary incontinence

    Page :S31

    L. Sung, J. Yu, J. Chung, C. Noh

    Plan Plan
  • ·MP-04.09: The SPARC procedure for the treatment of female stress urinary incontinence in the elderly

    Page :S31

    L. Sung, J. Yu, J. Chung, C. Noh

    Plan Plan
  • ·MP-04.10: Change of sexual function after midurethral sling procedure for stress urinary incontinence

    Page :S32

    D. Kim, H. Jung

    Plan Plan
  • ·MP-04.11: Success of midurethral slings in women with severe lower urinary tract symptoms

    Page :S32

    M. Ingber, F. Firoozi, S. Vasavada, H. Goldman

    Plan Plan
  • ·MP-04.12: Force of stream after sling therapy (FAST): safety and efficacy of a rapid discharge pathway based on subjective report

    Page :S33

    M. Ingber, S. Vasavada, C. Moore, R. Rackley, F. Firoozi, H. Goldman

    Plan Plan
  • ·MP-04.13: The early experience of simultaneous transobturator tape (TOT) and trocar-guided tension free vaginal mesh (Prolift) procedures in patients with stress urinary incontinence concomitant with anterior vaginal wall prolapse

    Page :S33

    C. Oh, N. Choi, S. Lee, C. Yoo, J. Cho, S. Park, S. Cho

    Plan Plan
  • ·MP-04.14: The efficacy of trans-section of synthetic sub-urethral sling tape for treatment of obstructive voiding symptoms following transobturator sling surgery after 3 years' follow up

    Page :S34

    G. Kim, J. Seo, D. Cho, J. Kim, H. Seo, J. Lee, W. Lee, Y. Seo, D. Kim, J. Kim

    Plan Plan
  • ·MP-04.15: The Management of Midurethral Sling (MUS) Tape Erosion

    Page :S34

    D. Kim, C. Park, T. Oh, E. Yoo

    Plan Plan
  • ·MP-05.01: Comparison of men with acute versus chronic urinary retention: etiology, clinical features, prostatic volume and histology

    Page :S34

    S. Van Vuuren, A. Zarrabi, C. Heyns

    Plan Plan
  • ·MP-05.02: Is prostatic resistive index helpful when choosing treatment option in patients with benign prostate hyperplasia?

    Page :S35

    A. Memip, C. Özden, Ý. Günay, T. Deren, S. Bulut, S. Koparal, Ö. Adsan

    Plan Plan
  • ·MP-05.03: Sources of variability when using only penile cuff test (PCT) can be rubbed out by combination with “VBN” method

    Page :S35

    F. Valentini, P. Nelson, D. Turner, S. Osaghae

    Plan Plan
  • ·MP-05.04: Bladder compliance is associated with the amplitude of detrusor overactivity in men with symptomatic benign prostatic enlargement associated with detrusor overactivity

    Page :S35

    N. Seki, N. Shahab, S. Kajioka, M. Takei, A. Yamaguchi, S. Naito

    Plan Plan
  • ·MP-05.05: A prospective study on the management of bladder lithiasis: is prostatic surgery a necessary adjunct?

    Page :S36

    G. Papadopoulos, P. Filippou, D. Volanis, E. Serafetinides, A. Ploumidis, I. Karyotis, D. Delakas

    Plan Plan
  • ·MP-05.06: Open prostatectomy versus transurethral resection of the prostate where do we stand in the new era? A randomized clinical trial

    Page :S36

    N. Simforoosh, H. Abdi, A. Kashi, S. Zare, A. Tabibi, A. Daneshdezfuli, A. Basiri, S.A.M. Ziaee

    Plan Plan
  • ·MP-05.07: Transurethral resection of the prostate combined with holmium laser enucleation (omega:wTURP) is safe and effective for treating benign prostatic hyperplasia

    Page :S36

    N. Tokuda, T. Kanou, F. Morokuma, M. Sugimoto, H. Iwai, T. Kobayashi

    Plan Plan
  • ·MP-05.08: Holmium laser enucleation of the prostate: non-mentor-aided learning curve and its proper estimation

    Page :S37

    S. Oh, M. Cho, J. Bae, J. Oh, J. Paick, C. Jeong

    Plan Plan
  • ·MP-05.09: Treatment of benign prostatic hyperplasia with plasmakinetic vaporization: six-year follow-up

    Page :S37

    O. Koca, M. Keleþ, C. Kaya, M. Günes, M. Öztürk, M. Karaman

    Plan Plan
  • ·MP-05.10: Is bipolar transurethral resection in saline (TURis) a good alternative for laser?

    Page :S37

    S. Falahatkar, G. Mokhtari, A. Farzan, A. Afsharimoghaddam, A. Enshaei, M. Kazemzadeh, A. Allahkhah

    Plan Plan
  • ·MP-05.11: Intraprostatic injection of botulinum toxin type-A (Dysport) relieves bladder outlet obstruction in men

    Page :S38

    S. Carl, S. Lashcke, J. Andreas

    Plan Plan
  • ·MP-05.12: Laser photovaporisation prostatectomy (PVP) in high hemorrhagic risk patients

    Page :S38

    M. Kharbouchi, A. Colau, G. Cariou

    Plan Plan
  • ·MP-05.13: National trends in the surgical therapy of benign prostatic hyperplasia in the United States (2002-2008)

    Page :S38

    S. Elliott, P. Bland, X. Yu, D. Caldwell, M. McBean

    Plan Plan  
  • ·MP-05.14: Incidence of urethral stenosis using Gyrus bipolar system: over 2000 TURP with 5 years follow-up: critical review of our department experience

    Page :S39

    R. Giulianelli, F. Pisanti, B. Gentile, S. Brunori, L. Mavilla, L. Albanesi, F. Attisani, T. Shestani, G. Vincenti

    Plan Plan
  • ·MP-05.15: Diode laser enucleation of the prostate: preliminary results of a novel technique

    Page :S39

    S. Yang, S. Chang

    Plan Plan
  • ·MP-06.01: The association of nocturia with sleep disorders, metabolic and chronic pulmonary conditions

    Page :S40

    S. Ayik, K. Bal, Y. Issi, A. Bolukbasi, G. Akhan

    Plan Plan
  • ·MP-06.02: Oral desmopressin in the treatment of nocturia in an aging population

    Page :S40

    A. Yassin, F. Saad, A. Haider

    Plan Plan
  • ·MP-06.03: Delayed development of hyponatremia in the patients of nocturia managed with desmopressin acetate (DDAVP)

    Page :S41

    J. Park, D. Kim, C. Kim, W. Cho, H. Chung

    Plan Plan
  • ·MP-06.04: Superior efficacy of fesoterodine over tolterodine: a pooled analysis of 2 head-to-head, placebo-controlled trials

    Page :S41

    P. Van Kerrebroeck, S. Swift, E. Rovner, D. Creanga, Z. Guan, J. Gong

    Plan Plan  
  • ·MP-06.05: Fesoterodine versus tolterodine for overactive bladder in older and younger subjects

    Page :S42

    P. Abrams, Z. Gong, D. Creanga

    Plan Plan
  • ·MP-06.06: The efficacy of tolterodine and tamsulosin combination therapy in female OAB patients

    Page :S42

    Y.S. Cho, K.J. Joo, H.J. Park, C.H. Kwon

    Plan Plan
  • ·MP-06.07: Correlation between overactive bladder (OAB) symptoms in female patients and urodynamic (UD) findings

    Page :S43

    A. Al-Zahrani, J. Gajewski

    Plan Plan
  • ·MP-06.08: Correlation between overactive bladder (OAB) symptoms in men and urodynamic (UD) findings

    Page :S43

    A. Al-Zahrani, J. Gajewski

    Plan Plan
  • ·MP-06.09: Morbidity of invasive urodynamics: experience after 750 procedures

    Page :S44

    C. Persu, V. Cauni, P. Geavlete

    Plan Plan
  • ·MP-06.10: Prospective randomized study for long term efficacy of percutaneous tibial nerve stimulation (PTNS) in patients with refractory overactive bladder: maintenance protocol

    Page :S44

    Y. Farahat, A. Elsaka, M. Rasheed

    Plan Plan
  • ·MP-06.11: Evaluation of long-term results of single time and repeated botulinum-A toxin (BTX-A) injections into the detrusor muscle for idiopathic overactive bladder syndrome (OAB)

    Page :S45

    C. Frohme, I. Beiter, J. Kranz, P. Olbert, R. Hofmann, A. Hegele

    Plan Plan
  • ·MP-06.12: An open label pilot study investigating the safety and efficacy of Botox® in 20 female patients with refractory symptoms of high urinary voiding frequency without incontinence

    Page :S45

    R. Casey, C. Andreou

    Plan Plan
  • ·MP-06.13: Outcomes and complications of botulinum toxin-A in non-neurogenic detrusor overactivity refractory to anticholinergics

    Page :S46

    Y. Bayoud, J. Ménard, F. Staerman

    Plan Plan
  • ·MP-06.14: Sacral neuromodulation for double incontinence: postoperative results from the patient's perspective

    Page :S46

    A. Petrolekas

    Plan Plan
  • ·MP-06.15: Changes in overactive bladder symptoms after mid-urethral sling surgery in patients with stress urinary incontinence plus overactive bladder symptoms: long-term results

    Page :S46

    J. Yoon, W. Cho, T. Kim, K. Moon

    Plan Plan
  • ·MP-06.16: Impact of PDE-5 inhibitors on clitoral blood flow after tension-free vaginal tape obturator (TVT-O) for stress urinary incontinence

    Page :S47

    A. Palmas, J. Fonseca

    Plan Plan

• Moderated Video Sessions

  • ·VID-1.01: Combined endoscopic and surgical treatment for bladder erosion by prolene mesh

    Page :S48

    S. Guercio, A. Ambu, F. Mangione, M. Mari, F. Vacca, M. Bellina

    Plan Plan
  • ·VID-1.02: Simultaneous correction of the anterior, apical prolapse and stress urinary incontinence with the anterior prolift system

    Page :S48

    I. Ignjatovic, M. Potic, N. Medojevic

    Plan Plan
  • ·VID-1.03: LESS transvesical VVF repair

    Page :S48

    P. Rao, A. Ansari, P. Rao

    Plan Plan
  • ·VID-1.04: Genitourinary reconstruction of urogenital sinus variant

    Page :S49

    B. Wadie

    Plan Plan
  • ·VID-01.05: One-stage reconstruction of the urethra and bladder neck, following severe obstetric trauma

    Page :S49

    B. Wadie, R. Faisal

    Plan Plan
  • ·VID-1.06: Management of rectourinary fistula: the York Mason approach

    Page :S49

    V. Flamand, R. Sanchez Salas, A. De Fourmestraux, E. Barret, F. Rozet, X. Cathelineau, M. Galiano, G. Vallancien

    Plan Plan
  • ·VID-1.07: Pelvic lipomatosis causing lower urinary tract symptoms and renal failure: surgical management with bilateral ureteric reimplantation

    Page :S49

    S. Smit, K. Du Toit, A. Zarrabi, A. Lecuona, W. Bates, C. Heyns

    Plan Plan
  • ·VID-2.01: 980nm diode laser enucleation of the prostate (DiLEP)

    Page :S50

    O. Buisan, J. Saladie, J. Ruiz-Dominguez, S. Bayona, L. Ibarz

    Plan Plan
  • ·VID-2.02: Bulkamide hydrogel: limits of a new bulking agent in the mini-invasive therapy of incontinence after prostatectomy

    Page :S50

    F. Mantovani, S. Maruccia, M. Spinelli, G. Cozzi, E. Tondelli, F. Rocco

    Plan Plan
  • ·VID-2.03: Reconstructive urethroplasty using porcine acellular matrix (S.I.S.): evolution of the grafting technique and results of 10 years' experience

    Page :S50

    F. Mantovani, S. Maruccia, M. Spinelli, D. Abed El Rahman, G. Cozzi, E. Tondelli, F. Rocco

    Plan Plan
  • ·VID-2.04: Purely transvaginal excision of mesh erosion involving the bladder

    Page :S51

    F. Firoozi, H. Goldman

    Plan Plan
  • ·VID-2.05: Tissue activated laser beam in the treatment of urethral stricture

    Page :S51

    V. Flamand, R. Sanchez Salas, A. De Fourmestraux, E. Barret, F. Rozet, X. Cathelineau, M. Galiano, G. Vallancien

    Plan Plan
  • ·VID-2.06: Combined perineal-prerectal approach and pedunculated penile skin flap autoplasty for complex bulbar-membranous urethral strictures

    Page :S51

    E. Austoni, G. Pini

    Plan Plan
  • ·VID-2.07: Free preputial skin dorsal onlay urethroplasty: our experience in 104 patients

    Page :S52

    S. Bapat, A. Mulay, R. Sharma, Y. Sovani, Y. Kshirsagar, V. Paramne, H. Choudhary

    Plan Plan

• Unmoderated Posters

  • ·UP-1.01: Impact of lower urinary tract symptoms on sexual function in patients with symptomatic prostatic disorders

    Page :S53

    M. Ali, H. Rashwan

    Plan Plan
  • ·UP-1.02: Urinary incontinence in patients with symptomatic benign prostatic enlargement: features and impact on sexual dysfunction

    Page :S53

    I. Ismail, M. Ali, M. Metawea, M. Bakr, H. Rashwan

    Plan Plan
  • ·UP-1.03: Lower urinary tract symptoms and sexual dysfunction in women: correlation of symptoms with urodynamic parameters

    Page :S53

    K. Bal, E. Aydinoglu, A. Bolukbasi, F. Sengul, B. Ozcift, A. Sezer

    Plan Plan
  • ·UP-1.04: Interest of uroflowmetry in prostatic hyperplasia

    Page :S53

    N. Benhatchi, O. Nouredine

    Plan Plan
  • ·UP-1.05: Clinical significance of detrusor after contraction

    Page :S54

    S. Cho, J. Yi, J. Park, M. Jeong, S. Oh

    Plan Plan
  • ·UP-1.06: Urinary diversion continence: pocket Casablanca

    Page :S54

    M. Khelil, H. El Neil, S. Elgachbour, K. Ksiri, A. Elmaataoui, R. Abouteib, A. Joual, R. Rabii, F. Meziane

    Plan Plan
  • ·UP-1.07: Bladder pheochromocytoma conservative treatment: endoscopic surgery coupled with open surgery

    Page :S54

    M. Khelil, H. El Neil, S. Elgachbour, K. Ksiri, A. Elmaataoui, R. Abouteib, A. Joual, R. Rabii, F. Meziane

    Plan Plan
  • ·UP-1.08: Lower urinary tract symptoms in patients with familial amyloidotic polyneuropathy

    Page :S55

    R. Farinha, T. Oliveira e Silva, L. Campos Pinheiro, E. Barroso, R. Mendes

    Plan Plan
  • ·UP-1.09: Impact of benign prostatic hyperplasia (BPH) on medically treated patients' quality of life

    Page :S55

    R. Fourcade, F. Lacoin, A. Slama, A. Gaudin, C. Le Fur, E. Michel, A. Sitbon, F. Cotté

    Plan Plan
  • ·UP-1.10: Urinary incontinence in obese people: urodynamics studies

    Page :S55

    B.C. Gentile, R. Giulianelli, S. Brunori, L. Albanesi, F. Pisanti

    Plan Plan
  • ·UP-1.11: Is TURP possible without postoperative irrigation?

    Page :S56

    O. Ghoundale, K. Bazine, M. Assebbane, E. Kasmaoui, M. Alami, M. Lezrek

    Plan Plan
  • ·UP-1.12: Anastomotic stricture after radical prostatectomy: risk factors

    Page :S56

    O. Capoun, T. Hanus, M. Babjuk, I. Pavlik, J. Dvoracek, K. Novak

    Plan Plan
  • ·UP-1.13: The efficacy and safety of combined therapy with tamsulosin and tolterodine for female patients with a maximal flow rate less than 12ml/sec

    Page :S56

    S. Kim, E. Hwang, C. Im, K. Oh, S. Jung, T. Kang, D. Kwon, K. Park, S. Ryu

    Plan Plan
  • ·UP-1.14: The effect of chronic prostatic inflammation and prostatic calculi on benign prostatic hyperplasia

    Page :S57

    H. Kim, Y. Cho, J. Kim, D. Lee, C. Han, Y. Lee, S. Kim, S. Cho

    Plan Plan
  • ·UP-1.15: The effect of intraprostatic chronic inflammation on benign prostate hyperplasia treatment

    Page :S57

    B. Kim, H. Chang, C. Kim, C.H. Park, J. Park

    Plan Plan
  • ·UP-1.16: Long-term effect of loxoprofen sodium on nocturia in patients with benign prostatic hyperplasia

    Page :S57

    H. Chang, B. Kim, C. Park, C. Kim, J. Park

    Plan Plan
  • ·UP-1.17: Is there a best method for measurement of Q tip angle?

    Page :S58

    C. Lee, J. Yun, D. Kim, Y. Jeon, N. Lee

    Plan Plan
  • ·UP-1.18: Sacral neuromodulation: utility if reprogramming during the initial test phase

    Page :S58

    C. Marchand, T. Ripert, R. Messaoudi, M. Azemar, F. Staerman, J. Ménard

    Plan Plan
  • ·UP-1.19: The role of urodynamics in the management of children's vesicoureteric reflux

    Page :S58

    M. Orsolya, E. Kiss, R. Boja

    Plan Plan
  • ·UP-1.20: Effect of increasing the dose of tamsulosin to 0.4 mg on dysuria associated with benign prostatic hyperplasia

    Page :S59

    T. Okamura, Y. Hirose, R. Ando, A. Nakane, H. Akita

    Plan Plan
  • ·UP-1.21: Large prostate volume is a risk factor of pyuria in patients with benign prostatic hyperplasia/lower urinary tract symptoms

    Page :S59

    S. Park, J. Lee, I. Kang, D. Han, I. Seo, H. Jeong, J. Rim

    Plan Plan
  • ·UP-1.22: Differential diagnosis of lower urinary tract symptoms in elderly men: a 7-year retrospective analysis of symptoms and urodynamics

    Page :S59

    J. Park, D. Kim, W. Cho, C. Kim, H. Chung

    Plan Plan
  • ·UP-1.23: Evaluation of lower urinary tract symptoms in men with type II decompression sickness

    Page :S60

    E. Patris, V. Patris, I. Efthimiou, C. Kalaitzis, S. Giannopoulos, S. Giannakopoulos, S. Touloupidis

    Plan Plan
  • ·UP-1.24: Relationship between clinical outcome of photoselective vaporization prostatectomy and pressure flow study

    Page :S60

    Y. Seo, S. Kisik, H. Jeongmoon, Y. Cheolsoo

    Plan Plan
  • ·UP-1.25: Urodynamic alterations of patients with varying degrees of cystocele

    Page :S60

    J. Lee, D. Shin, W. Lee, S. Bang, J. Lee, B. Park, C. Park, S. Park

    Plan Plan
  • ·UP-1.26: The role of alpha 1(A) Adrenoceptor antagonist tamsulosin for the treatment of patients with lower urinary tract symptoms in women: the effect of nocturia and sleep quality

    Page :S61

    S.B. Ryu, S. Kim, E. Hwang, C. Im, K. Oh, S. Jung, T. Kang, D. Kwon, K. Park

    Plan Plan
  • ·UP-1.27: TRUS assisted transurethral incision of ejaculatory ducts (TUIED): a novel technique

    Page :S61

    M. Veeramoni, S. Mishra, A. Kurien, A. Ganpule, R. Sabnis, M. Desai

    Plan Plan
  • ·UP-1.28: Additive tolterodine for elderly male LUTS in Taiwan

    Page :S61

    H. Kuo, S. Chung, W. Wu

    Plan Plan
  • ·UP-1.29: GreenLight HPS laser photoselective vaporisation prostatectomy in a district General Hospital

    Page :S62

    H. Alnajjar, J. Bondad, D. Magrill, S. Gordon, P. Le Roux

    Plan Plan
  • ·UP-1.30: Comparison of clinical outcome between benign prostatic hyperplasia patients with and without extension of the prostate into urinary bladder after transurethral resection of prostate

    Page :S62

    S. Chen

    Plan Plan
  • ·UP-1.31: Factors that Contribute to improve Qmax after transurethral resection of the prostate

    Page :S62

    I.R. Cho, A.G. Lee, S.Y. Cho, J.Y. Chung

    Plan Plan
  • ·UP-1.32: Predictors of successful cessation of alpha-blockers in patients with benign prostatic hyperplasia/lower urinary tract symptoms: a pilot study

    Page :S63

    K. Cho, S. Lee, S. Park, D. Kim, T. Yoo

    Plan Plan
  • ·UP-1.33: Could elevated prostate-specific antigen be a useful marker for bladder outlet obstruction?

    Page :S63

    S. Choi, J. Chung

    Plan Plan
  • ·UP-1.34: Changes in lower urinary tract symptoms after cryosurgical ablation for prostate cancer

    Page :S63

    S. Choi, J. Chung

    Plan Plan
  • ·UP-1.35: An analysis of the factors of bladder irritation symptoms after transurethral resection of the prostate (TURP)

    Page :S64

    H. Chung, J. Song, S. Kim, K. Kim, J. Jung

    Plan Plan
  • ·UP-1.36: Definitive assessment of early post-operative symptoms after laser photovaporization of the prostate (PVP): validation of a dedicated questionnaire

    Page :S64

    J. Cornu, J. Terrasa, M. Tligui, P. Sèbe, L. Peyrat, C. Ciofu, O. Traxer, O. Cussenot, F. Haab, B. Lukacs

    Plan Plan
  • ·UP-1.37: Prospective evaluation of transurethral needle ablation (TUNA) procedure in an ambulatory setting

    Page :S64

    J. Cornu, F. Desgranchamp, A. De la taille, B. Lukacs

    Plan Plan
  • ·UP-1.38: Short-term results on efficacy and safety of high power (80W) KTP (Potassium-Titanyl-Phosphate) laser vaporization of the prostate

    Page :S65

    Y. Kim, J. Lee

    Plan Plan
  • ·UP-1.39: Long intraprostatic urethral length as a cause of lower urinary tract symptoms in patients with prostate volume less than 25 cm³

    Page :S65

    S. Lee, D. Park, H. Jeon, D. Choi, I. Gong

    Plan Plan
  • ·UP-1.40: Short-term results of bladder hydrodistention for interstitial cystitis in young adult men

    Page :S65

    S. Min, S. Kim, S. Lee, M. Jo

    Plan Plan
  • ·UP-1.41: The role of trial without catheter in the initial management of acute urinary retention due to benign prostatic hyperplasia

    Page :S66

    A. Cumpanas, M. Botoca, R. Minciu, M. Fahes, O. Pojoga, L. Daminescu, V. Bucuras, F. Miclea

    Plan Plan
  • ·UP-1.42: The prevalence of benign prostate hyperplasia in a rural community of South Korea

    Page :S66

    H. Moon, J. Kwon, S. Park, Y. Kim, H. Park, H. Choi, S. Kim, B. Choi, T. Lee

    Plan Plan
  • ·UP-1.43: Penetration depth is key: the optimal treatment of BPH (Benign Prostatic Hyperplasia) using multi-disciplinary laser DIOLAS LFD 3000 for the photoselective vaporization of the prostate

    Page :S66

    J. Neymeyer, W. Abdul-Wahab Al-Ansari, F. Abdel-Aziz, A. Gunnemann, M. Beer

    Plan Plan
  • ·UP-1.44: Laser vaporization for the treatment of BPH: prospective study with an eighteen-month follow-up

    Page :S67

    A. Nouri, F. N'Guebou, B. Makhoul, S. Bassard, R. Fourcade

    Plan Plan
  • ·UP-1.45: Efficacy of TURP for the treatment of BPH in patients with diabetes mellitus

    Page :S67

    G. Papadopoulos, I. Karyotis, D. Volanis, A. Ploumidis, G. Garaganis, E. Serafetinides, D. Delakas

    Plan Plan
  • ·UP-1.46: Results of retropubic prostatectomy and transurethral resection of prostate: comparison of results and investigation of cause of different results

    Page :S67

    S.W. Park, S.G. Jung, T.N. Kim, D.G. Shin, S.D. Lee, J.Z. Lee, M.K. Chung

    Plan Plan
  • ·UP-1.47: A novel technique combining bipolar and LESS Enucleation for BPH

    Page :S68

    P. Rao, M. Desai, B. Chen, R. Sotelo, C.X. Liu

    Plan Plan
  • ·UP-1.48: Management of acute urinary retention associated with benign prostatic hyperplasia in real life practice in Thailand

    Page :S68

    K. Ratana-Olarn, Reten - World Thailand Study 2

    Plan Plan
  • ·UP-1.49: Management of chronic retention: overcoming a dilemma

    Page :S68

    R. Sabnis, S. Mishra, A. Bhattu, V. Mutthu, M. Desai

    Plan Plan
  • ·UP-1.50: Tadalafil monotherapy is as efficacious as tamsulosin in patients with LUTS secondary to BPH: results of first head-on comparative, prospective, randomized study to evaluate the efficacy of tadalafil and tamsulosin, in patients with LUTS secondary to BPH

    Page :S69

    R. Sabnis, V. Jaoin, S. Mishra, A. Kurian, M. Veeramoni, M. Desai

    Plan Plan
  • ·UP-1.51: Tolterodine and tamsulosin for treatment of men with benign prostatic hyperplasia and lower urinary tract symptoms

    Page :S69

    V. Stanca, R. Maxim, Y. El Aidi, P. Prundus, I. Coman

    Plan Plan
  • ·UP-1.52: Lower urinary tract symptoms in men with prostate cancer: correlation with cancer control

    Page :S69

    J. Stander, C. Van der Walt, C. Heyns

    Plan Plan
  • ·UP-1.53: The introduction of a prostate holmium laser service to a district general hospital (DGH)

    Page :S70

    L. Vyas, C. Kastner, R. Beard

    Plan Plan
  • ·UP-1.54: The alteration of autonomic nervous system activity in women with urge urinary incontinence

    Page :S70

    J. Choi, J. Kim, H. Kim, J. Yeo, Y. Seo, Y. Kim, J. Lee

    Plan Plan
  • ·UP-1.55: Comparison of urodynamics between ischemic and hemorrhagic stroke patients: can we suggest the category of urinary dysfunction in patients with cerebrovascular accident according to type of stroke?

    Page :S71

    S. Choi, K. Yoo, H. Lee

    Plan Plan
  • ·UP-1.56: Effectiveness of botulinum toxin Type A in the management of neurogenic lower urinary tract dysfunction

    Page :S71

    G. Catalan, R. Gómez, P. Marchetti, A. Vidal

    Plan Plan
  • ·UP-1.57: Effect of Clean Intermittent Catheterization on PSA Levels of Spinal Cord Injured Patients

    Page :S71

    F. Torricelli, M. Lucon, C. Gomes, F. Vicentini, M. Srougi, H. Bruschini

    Plan Plan
  • ·UP-1.58: Efficacy of clean intermittent catheterization (CIC) for urinary incontinence in children with neurogenic bladder dysfunction secondary to myelodysplasia

    Page :S72

    K. Obara, T. Mizusawa, E. Isahaya, K. Suzuki, N. Hara, K. Takahashi

    Plan Plan
  • ·UP-1.59: Urological features of quadriplegia: six years of experience

    Page :S72

    C. Persu, V. Cauni, P. Geavlete

    Plan Plan
  • ·UP-1.60: Preliminary report of the first experience of sacral neuromodulation in Iranian patients with voiding dysfunction

    Page :S72

    F. Sharifiaghdas, M.H. Soltani

    Plan Plan
  • ·UP-1.61: Prostatic inflammation and prostate cancer: is there evidence for a link?

    Page :S73

    P. Engelhardt, H. Brustmann, S. Seklehner, C. Riedl

    Plan Plan
  • ·UP-1.62: Pelvic drain can be avoided after transvesical prostatectomy for prostate benign hyperplasia

    Page :S73

    O. Ghoundale, D. Touiti

    Plan Plan
  • ·UP-1.63: Use of hyperbaric oxygen therapy for hemorrhagic cystitis secondary to pelvic radiotherapy

    Page :S73

    C. Parra, R. Gómez, A. Felmer, O. Castillo, G. Rubio

    Plan Plan
  • ·UP-1.64: Impact of dutasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia

    Page :S74

    S. Hong, J. Oh, C. Jeong, S. Jeong, S. Byun, S. Lee

    Plan Plan
  • ·UP-1.65: Effect of silodosin on ejaculation function and qol in patients with lower urinary tract syndrome (LUTS)

    Page :S74

    T. Iwamoto, T. Hasegawa, N. Minagawa, F. Nukui, Y. Kinoshita, Y. Satomi, A. Furuhata, K. Kawabe

    Plan Plan
  • ·UP-1.66: Correlation between serum parathyroid hormone and prostate size in patients with benign prostatic hyperplasia

    Page :S74

    W. Kim, Y. Kim, S. Yun, S. Lee, W. Kim

    Plan Plan
  • ·UP-1.67: Diagnostic value of functional bladder capacity, urine osmolality and daytime storage symptoms for severity of nocturnal enuresis

    Page :S75

    T. Kim, J. Kim

    Plan Plan
  • ·UP-1.68: Results of patients' questionnaires after photoselective vaporisation of the prostate: single institution survey

    Page :S75

    J. Klecka, M. Hora, P. Behounek, V. Eret, P. Stransky, T. Urge

    Plan Plan
  • ·UP-1.69: Cystocele plication risk (CPR) trial: a pilot study

    Page :S75

    V. Miranda, H. Drutz, M. Alarab, K. Murphy, D. Lovatsis

    Plan Plan
  • ·UP-1.70: Impact of preoperative urinary dysfunction on functional outcomes following open radical prostatectomy

    Page :S76

    S. Yamamoto, J. Yonese, S. Urakami, S. Kitsukawa, N. Numao, Y. Kubo, G. Sukegawa, Y. Yasuda, I. Fukui

    Plan Plan
  • ·UP-1.71: Urinary continence after open, laparoscopic and robotic prostatectomy: a single center experience

    Page :S76

    Y. El Aidi, N. Crisan, B. Feciche, D. Stanca, C. Lapusan, C. Manea, P. Prundus, C. Neiculescu, V. Ona, I. Coman

    Plan Plan
  • ·UP-1.72: Antegrade approach provides higher and earlier continence rates and better health-related quality of life on urination following radical prostatectomy

    Page :S76

    A. Fujisaki, Y. Shiga, M. Kurobe, T. Iwabuchi, S. Minagawa, T. Sugimura, F. Endo, M. Yashi, K. Hattori, O. Muraishi

    Plan Plan
  • ·UP-1.73: Primary results of Argus readjustable male sling after 15 cases

    Page :S77

    T. Karaolides, T. Kalogeropoulos, E. Koutsiaris, A. Konandreas, T. Arvanitakis

    Plan Plan
  • ·UP-1.74: Evaluation and classification of sphincter lesions due to radical prostatectomy (RP)

    Page :S77

    R. Karig, J. Bagner, H. Gerullis, C. Eimer, S. Quast, T. Otto

    Plan Plan
  • ·UP-1.75: Results of simultaneous implantation of inflatable penile prosthesis and bone anchored bulbourethral sling after radical prostatectomy

    Page :S77

    R. Oliveira, A. Resende, M. Guimaraes, N. Tomada, P. Vendeira, P. Dinis, F. Cruz

    Plan Plan
  • ·UP-1.76: Capio RP suturing device for vesico-urethral anastomosis improves urinary continence and post-surgical strictures rates after radical retropubic prostatectomy

    Page :S78

    G. Perugia, F. Iori, D. Di Viccaro, S. Teodonio, A. Chinazzi, G. Borgoni, F. De Luca, M. Liberti

    Plan Plan
  • ·UP-1.77: Postoperative status of bladder outflow and early cathter removal after radical retropubic prostatectomy

    Page :S78

    G. Perugia, G. Di Natale, A. Chinazzi, D. Di Viccaro, S. Teodonio, G. Bova, G. Borgoni, M. Liberti

    Plan Plan
  • ·UP-1.78: The adjustable transobturator tape (TOT) for post-prostatectomy incontinence

    Page :S78

    F. Yalcinkaya, M. Sertcelik, O. Yigitbasi, O. Karabacak, H. Bokurt

    Plan Plan
  • ·UP-1.79: The association between lower urinary tract symptoms and vascular risk factors in aging men: Hallym aging study

    Page :S79

    S. Lee, S. Kim, W. Lee, C. Oh, S. Cho, C. Park, S. Lee, H. Kim, N. Choi

    Plan Plan
  • ·UP-1.80: Robotic-assisted laparoscopic radical cystectomy (RARC) with extracorporeal urinary diversion and robotic-assisted laparoscopic partial cystectomy (RAPC)

    Page :S79

    S. Jung, Y. Seo, S. Kim, J. Ha, M. Gil, S. Yoon, J. Chung, S. Kim

    Plan Plan
  • ·UP-2.01: Endoscopic removal of spontaneously migrated IUD to the bladder

    Page :S80

    B. Jorge Pereira, E. Retroz, Á. Brandõ, H. Coelho, R. Borges, R. Leaõ, V. Grenha, F. Sobral

    Plan Plan
  • ·UP-2.02: The Effect of Tamsulosin in Female Patients with Lower Urinary Tract Symptoms and Predictive Factors for Therapeutic Outcome: Multicenter, Prospective Study

    Page :S80

    S.H. Lee, S.Y. Kim, W.K. Lee, C.Y. Oh, H. Kim, N.G. Choi, S.W. Lee, J.H. Kim, H.C. Chung, C.M. Park

    Plan Plan
  • ·UP-2.03: Improvement of lower urinary tract dysfunction after trocar-guided transvaginal mesh repair of pelvic organ prolapse in elderly women

    Page :S80

    S.J. Lee, D.C. Park

    Plan Plan
  • ·UP-2.04: Transvaginal repair of genital prolapse with prolift system: morbidity and anatomic outcomes after 5 years of use: a multicentric study

    Page :S81

    T. Ripert, J. Ménard, R. Messaoudi, M. Azemar, B. Samarcq, Y. Nicolacopoulos, L. Bednarzyck, F. Staerman

    Plan Plan
  • ·UP-2.05: Female urethral diverticulum and the result of surgical repair

    Page :S81

    F. Sharifiaghdas, N. Mortazavi, N. Ghaderian

    Plan Plan
  • ·UP-2.06: Vesicovaginal fistulas: the surgical management in our center

    Page :S81

    E. Golmayo Muñoz-Delgado, A. Sanchis Bonet, J. Olivares, I. Rodriguez Cruz, M. Sanchez Chapado

    Plan Plan
  • ·UP-2.07: Disorders in urinary bladder micturition after rectal operations

    Page :S82

    M. Addali, V. Zugor, J. Witt, D. Porres

    Plan Plan
  • ·UP-2.08: TVT vs. TOT: a comparison of continence results, complications and quality of life after a median follow-up of 48 months

    Page :S82

    M. Addali, V. Zugor, J. Witt, D. Porres

    Plan Plan
  • ·UP-2.09: Consideration on surgical results and quality of life in the surgical repair of anterior vaginal prolapse

    Page :S82

    T. Brancato, P. Nupieri, R. d'Ascenzo, G. Orsolini, G. Paulis, G. Valducci, R. Alvaro

    Plan Plan
  • ·UP-2.10: Midterm results of continence, complications and quality of life after TOT procedure

    Page :S83

    T. Brancato, P. Nupieri, R. D'Ascenzo, G. Orsolini, G. Paulis, G. Valducci, R. Alvaro

    Plan Plan
  • ·UP-2.11: A comparative analysis of MiniArc™ and Monarc™ sub-urethral slings for female stress urinary incontinence

    Page :S83

    A. Brown, R. Khafagy, S. Kabir, M. Kimuli, G. Urwin

    Plan Plan
  • ·UP-2.12: Laparoscopic sacrocolpopexy: initial experience in 10 cases

    Page :S83

    O. Castillo, A. Foneron, R. Gómez, I. Vidal-Mora, G. Rubio, R. Campos

    Plan Plan
  • ·UP-2.13: Characteristics of lower urinary tract symptoms and efficacy of treatment with desmopressin in female patients

    Page :S84

    H.J. Cho, S.J. Kim, B.I. Yun, S.H. Hong, J.Y. Lee, S.W. Kim, T.K. Hwang

    Plan Plan
  • ·UP-2.14: The effects of the REMEEX system^® for treatment of re-do urinary incontinence and intrinsic sphincteric deficiency

    Page :S84

    H. Jung, P. Song, J. Kim, T. Oh, J. Park

    Plan Plan
  • ·UP-2.15: The effect of stage II or less cystocele on voiding pattern after midurethral sling

    Page :S84

    H. Kim, S. Paick, Y. Lho, H. Park, W. Park, M. Jo

    Plan Plan
  • ·UP-2.16: The influence of obesity on patients with female stress urinary incontinence

    Page :S85

    Y. Kim, W. Kim, D. Tchey, S. Yun, S. Lee, W. Kim, S. Jo

    Plan Plan
  • ·UP-2.17: Postoperative voiding difficulty after midurethral sling surgery in female stress urinary incontinence: when does it get better?

    Page :S85

    D. Lee, J. Kim, Y. Kim, J. Choi, H. Kim, T. Lee, W. Park

    Plan Plan
  • ·UP-2.18: Evaluation of a modified novel vaginal flap operation in stress urinary incontinence (SUI) using dynamic MRI

    Page :S85

    A. Fayed, A. Abdelkarim, W. Mahfouz, S. Elsalmy

    Plan Plan
  • ·UP-2.19: Adjustable devices in the treatment of stress incontinence

    Page :S86

    S. Middela, R. Hejj, W. Chow, D. Barnes

    Plan Plan
  • ·UP-2.20: Sacrospinous ligament fixation for vaginal vault prolapse with a reusable suturing device (RSD-Ney) in 5 minutes

    Page :S86

    J. Neymeyer, M. Abou-Dakn, W. Abdul-Wahab Al-Ansari, E. Greiner, S. Kassin, M. Beer

    Plan Plan  
  • ·UP-2.21: Preliminary report of the readjustable sling procedures for treatment of stress urinary incontinence with intrinsic sphincter deficiency in Korean females

    Page :S87

    J.H. Noh, H.J. Jeong

    Plan Plan
  • ·UP-2.22: Initial experience of cystocele and stress incontinence repair with prolift system and concomitant tension-free vaginal tape (TVT)

    Page :S87

    S. Paick, H. Kim, H. Park, Y. Lho

    Plan Plan
  • ·UP-2.23: Voiding pattern after ‘U-method' TVT-Secur: is it obstructive?

    Page :S87

    P. Richard, L.-O. Gagnon, L.M. Tu

    Plan Plan
  • ·UP-2.24: TOT surgery experience with Unitape-T-Plus mesh

    Page :S88

    A. Salazar, A. Miranda, C. Montiglio, C. Vicherat, J. Sandoval, S. Badilla, E. Schwarze, G. Sarrat

    Plan Plan
  • ·UP-2.25: Early urinary catheter removal after TOT Procedure: evaluation of immediate postoperative voiding

    Page :S88

    A. Salazar, A. Miranda, C. Montiglio, A. Acuña, N. Orellana, C. Vicherat, S. Badilla

    Plan Plan
  • ·UP-2.26: Short-term results of mini-sling TVT secure and rectus facial sling surgery in the treatment of female stress urinary incontinence

    Page :S89

    F. Sharifiaghdas, M. Mirzaei

    Plan Plan
  • ·UP-2.27: The effect of postoperative physical activity on the outcomes of transobturator tape procedure

    Page :S89

    J. Lee, D. Shin, S. Bang, J. Lee, B. Park, C. Park, W. Lee

    Plan Plan
  • ·UP-2.28: Comparison of TOA and TOT for treating female stress urinary incontinence: short-term outcomes

    Page :S89

    K. Song, C. Sul, Y. Na, J. Lim, Y. Chang

    Plan Plan
  • ·UP-2.29: Prevalence of stress urinary incontinence in Romania

    Page :S90

    C. Surcel, C. Mirvald, C. Chibelean, D. Avram, C. Gingu, A. Iordache, C. Savu, M. Harza, M. Manu, I. Sinescu

    Plan Plan
  • ·UP-2.30: TVT and vaginal prolapse: a long-term follow-up

    Page :S90

    C. Topuzovic, C. Tulic

    Plan Plan
  • ·UP-2.31: Is there a place for nonsurgical management of female stress incontinence?

    Page :S90

    C. Topuzovic, T. Pejcic

    Plan Plan
  • ·UP-2.32: Sacrocolpopexy for pelvic floor reconstruction in pelvic organ prolapse causing female stress urinary incontinence: first results of a minimally invasive laparoscopic approach

    Page :S91

    R. Zimmermann, S. Jeschke, G. Janetschek

    Plan Plan
  • ·UP-2.33: Estimation of female urethral elasticity and flexibility from cystourethroscopic image

    Page :S91

    K. Horiuchi, T. Ishii, Y. Naya, T. Nakada, T. Yamanishi, T. Igarashi

    Plan Plan
  • ·UP-2.34: Impact on quality of life of botulinum toxin-a in non-neurogenic detrusor overactivity refractory to anticholinergics

    Page :S91

    Y. Bayoud, J. Ménard, F. Staerman

    Plan Plan
  • ·UP-2.35: Total urgency score (TUS) as a measure of frequency and urgency in SUNRISE

    Page :S92

    L. Cardozo, J. Mikulas, G. Amarenco, T. Drogendijk, G. Compion

    Plan Plan
  • ·UP-2.36: Effectiveness and tolerability of a combined medication of two different anticholinergics for patients with symptoms of overactive bladder

    Page :S92

    S.E. Lee, S.J. Jeong, J. Yi, H. Park, J.J. Oh, C.W. Jeong, H. Jeong, C.Y. Yoon, S.K. Hong, S.S. Byun

    Plan Plan
  • ·UP-2.37: Impact of prostate volume on the efficacy of solifenacin succinate monotherapy in men with lower urinary tract symptoms and overactive bladder symptoms

    Page :S93

    S. Kitayama, R. Takazawa, T. Tsujii, T. Yoshikawa

    Plan Plan
  • ·UP-2.38: Rate and predictive factors of the anticholinergic add-on therapy in men with residual overactive bladder symptom after 4 weeks of ⍺-blocker monotherapy

    Page :S93

    S.E. Lee, W.H. Park, K.S. Lee, H.N. Lee, Y.S. Lee, H.Y. Choi, M.S. Choo

    Plan Plan
  • ·UP-2.39: Symptom change after discontinuation of successful anticholinergic treatment in patients with overactive bladder symptoms: prospective, randomized, multicenter trial

    Page :S93

    M.S. Choo, H.M. Lee, K.S. Lee, H.Y. Choi, S.E. Lee, W.H. Park

    Plan Plan
  • ·UP-2.40: Influence of overactive bladder on falls: study on females aged 40 and older in urban and rural communities

    Page :S94

    H. Moon, J. Kim, S. Park, Y. Kim, H. Park, H. Choi, S. Kim, B. Choi, T. Lee

    Plan Plan
  • ·UP-2.41: A comprehensive patient support programme improves persistence with solifenacin in overactive bladder (OAB)

    Page :S94

    E. Siddiqui, D. Wood, G. Compion

    Plan Plan
  • ·UP-2.42: Phasic or terminal detrusor overactivity in women: age, urodynamic findings and sphincter behavior relationships

    Page :S95

    F. Valentini, B. Marti, G. Robain, P. Nelson, S. Osaghae

    Plan Plan
  • ·UP-2.43: Nervous control of lower urinary tract (LUT) during detrusor overactivity (DO): an approach using modeled analysis of filling cystometries and pressure-flow studies

    Page :S95

    F. Valentini, P. Nelson, S. Osaghae

    Plan Plan
  • ·UP-2.44: An electronic tool to support the selection of patients with overactive bladder syndrome for sacral neuromodulation

    Page :S95

    P. Van Kerrebroeck, E. Chartier-Kastler, D. Castro-Diaz, D. De Ridder, S. Elneil, A. Kaufmann, T. Kessler, M. Spinelli, J. Wachter, H. Stoevelaar

    Plan Plan
  • ·UP-2.45: Orthotopic enterocystoplasty for bladder substitution: 120 cases

    Page :S96

    F. Benlamssouhi, M. Elbaghouli, A. Joual, R. Rabii, H. Fekak, R. Aboutaib, M. Dakir, A. Debagh, S. Bennani, F. Meziane

    Plan Plan
  • ·UP-2.46: Why Studer orthotopic bladder? observation of 110 patients

    Page :S96

    D. Shishkov, D. Mateev, V. Angelov, R. Starev, A. Sarachev

    Plan Plan
  • ·UP-2.47: Quality of life after orthotopic urinary diversion

    Page :S96

    S. Vojinov, D. Jeremic, I. Levakov, V. Sekulic, J. Djozic, G. Marusic

    Plan Plan
  • ·UP-2.48: Long-term tolerability and efficacy of pentosan polysulphate sodium in the treatment of patients with bladder pain syndrome (BPS)

    Page :S97

    A. Al-Zahrani, J. Gajewski

    Plan Plan
  • ·UP-2.49: Prospective study on prostate biopsy in patients with high serum PSA in consideration of prostatic inflammation

    Page :S97

    I. Cho, Y. Choi, S. Cho, J. Chung

    Plan Plan  
  • ·UP-2.50: Glycosaminoglycans in bladder biopsies and in urine as possible markers for intestitial cystitis/painful bladder syndrome

    Page :S98

    M. Lucon, J. Dreyfuss, A. Silva, K. Leite, H. Nader, M. Srougi, H. Bruschini

    Plan Plan  
  • ·UP-2.51: Comparison of Maki's technique and sonication in the diagnosis of microbial ureteral stent colonization: a randomized prospective study

    Page :S98

    G. Bonkat, A. Bachmann, M. Rieken, C. Rentsch, S. Wyler, T. Gasser, A. Widmer

    Plan Plan
  • ·UP-2.52: The relationship between microbial ureteral stent colonisation and male lower urinary tract symptoms

    Page :S99

    G. Bonkat, A. Bachmann, M. Rieken, C. Rentsch, S. Wyler, T. Gasser, A. Widmer

    Plan Plan
  • ·UP-2.53: Correlation between post-void residual urine volume and urinary tract infection in asymptomatic men visited for prostate examination

    Page :S99

    Y.H. Cho, H.W. Kim

    Plan Plan
  • ·UP-2.54: What volume of post-void residual urine causes urinary tract infection?

    Page :S99

    T.S. Jung, J.H. Song, K.H. Cho, M.H. Song, D.S. Kim, C.H. Lee, Y.S. Jeon, N.K. Lee

    Plan Plan
  • ·UP-2.55: Ciprofloxacin in the treatment of urinary tract infections in general practice

    Page :S100

    M. Khelil, H. El Neil, S. Elgachbour, K. Ksiri, A. Elmaataoui, R. Abouteib, A. Joual, R. Rabii, F. Meziane

    Plan Plan
  • ·UP-2.56: Urogenital tuberculosis (about 116 cases)

    Page :S100

    M. Khelil, H. El Neil, S. Elgachbour, A. Elmaataoui, K. Ksiri, R. Abouteib, A. Joual, R. Rabii, F. Meziane

    Plan Plan
  • ·UP-2.57: Antimicrobial effect of lactobacillus in a rat model of escherichia coli lower urinary tract infection: a preliminary study

    Page :S100

    C. Han, H. Kim, Y. Cho

    Plan Plan
  • ·UP-2.58: Schistosomiasis: unusual cause of LUTS in Europe

    Page :S101

    R. Leão, P. Azinhais, B. Pereira, R. Borges, V. Grenha, H. Coelho, E. Retroz, F. Sobral

    Plan Plan
  • ·UP-2.59: Large retroperitoneal abscess complicating neurogenic lower urinary tract dysfunction

    Page :S101

    E. Patris, I. Efthimiou, C. Kalaitzis, C. Zachariadis, S. Giannopoulos, S. Giannakopoulos, G. Tsakaldimis, S. Touloupidis

    Plan Plan
  • ·UP-2.60: Clinical significance of postoperative bacteriouria after transurethral surgery: results of a prospective multicenter study

    Page :S101

    A. El Basri, A. Petrolekas, G. Cariou, A. Cortesse, A. Colau, F. Bruyère

    Plan Plan
  • ·UP-2.61: Possibility of antibiotic usage according to their activity spectrum and price for uncomplicated urinary tract infections on the primary level of healthcare in the region

    Page :S101

    Z. Rainauli, S. Rainauli, N. Rainauli

    Plan Plan
  • ·UP-2.62: Intravesical instillation of hyaluronic acid in the treatment of recurrent urinary tract infection in women

    Page :S102

    F. Sharifiaghdas, N. Hamzehi Esfahani

    Plan Plan
  • ·UP-2.63: The role of neonatal circumcision in prevention of urinary infection: a large prospective study with long term follow-up using Plastibell

    Page :S102

    N. Simforoosh, A. Tabibi, S.A. Khalili, M.H. Soltani, A. Afjehi, F. Aalami, H. Bodoohi

    Plan Plan
  • ·UP-2.64: Perioperative morbidity and mortality in Fournier's gangrene

    Page :S102

    C. Surcel, C. Mirvald, C. Chibelean, C. Gingu, V. Cerempei, D. Avram, C. Dudu, V. Zogas, I. Sinescu

    Plan Plan
  • ·UP-2.65: Life saving D-J stenting in lower urinary tract infection: really a daring step or not?

    Page :S103

    M. Umer

    Plan Plan
  • ·UP-2.66: AUA recommended preparations (antibiotic prophylaxis and cleansing enema) are important to prevent febrile complications in transrectal ultrasonography guided prostate biopsy

    Page :S103

    J. Yu, L. Sung, J. Chung, C. Noh

    Plan Plan
  • ·UP-2.67: Anastomotic stricture after radical prostatectomy (about 7 cases)

    Page :S103

    J. Maarouf, J. Ghorbel, Z. Gammoudi, M. Dridi, R. Khiari, S. Ghozzi, H. Khouni, N. Ben Rais

    Plan Plan
  • ·UP-2.68: Low power holmium laser urethrotomy can be safely performed under local anesthesia in urethral stricture patients following transurethral resection of the prostate

    Page :S103

    K. Cho, S. Lee, S. Park, D. Kim, D. Lee, T. Yoo

    Plan Plan
  • ·UP-2.69: York Mason approach: a good technique for the management of urethrorectal fistulas

    Page :S104

    M. Statoua, K. El Khader, J. El Ghanmi, T. El Karmouni, K. Tazi, A. El Koutani, A. Ibn Attya, A. Al Hachimi

    Plan Plan
  • ·UP-2.70: Incidence of fossa navicularis strictures in retropubic radical prostatectomy

    Page :S104

    R. Giulianelli, F. Pisanti, B. Gentile, S. Brunori, L. Mavilla, L. Albanesi, F. Attisani, T. Shestani, G. Vincenti

    Plan Plan
  • ·UP-2.71: Substitution urethroplasty

    Page :S104

    D. Sharma

    Plan Plan
  • ·UP-2.72: Urethroplasty in multiple stages using buccal mucosa grafts

    Page :S104

    K. Vander Eeckt, S. Joniau

    Plan Plan
  • ·UP-2.73: End-to-end repair or augmented anastomosis for single-stage bulbar urethroplasty in short urethral strictures?

    Page :S105

    K. Vander Eeckt, S. Joniau

    Plan Plan
  • ·UP-2.74: Male urethral carcinoma: does stricture urethra / multiple instrumentation predispose it?

    Page :S105

    M. Veeramoni, S. Mishra, A. Kurien, A. Ganpule, R. Sabnis, M. Desai

    Plan Plan
  • ·UP-2.75: Outcome of daycase optical urethrotomy

    Page :S105

    S. Venugopal, D. Schoeman, A. Farrier, S. Das, C. Powell, B. Pettersson

    Plan Plan
  • ·UP-2.76: A comparative study on the clinical effects of silodosin and naftopidil in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia

    Page :S106

    T. Shirakawa, T. Haraguchi, M. Matsumoto, S. Morishita, K. Minayoshi, J. Miyazaki, Y. Yamada, K. Tanaka, A. Takenaka, M. Fujisawa

    Plan Plan